Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Dermatology | Pediatrics/Neonatology | Family Medicine
Search Medical Condition
Eczema (Atopic Dermatitis - Pediatric) Clinical Trials
A listing of Eczema (Atopic Dermatitis - Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (16) clinical trials
An Open-Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
The purpose of this study is to evaluate the safety and tolerability of topical INCB018424 cream applied to pediatric subjects (≥ 12 to 17 years) with atopic dermatitis (AD).
Pediatric Atopic Dermatitis (Eczema)
Wake Research Associates is enrolling volunteers with eczema in a clinical research study testing the effectiveness, tolerability and safety of an investigational medication.
Eczema (Atopic Dermatitis)
Do you or your child suffer from eczema, also known as atopic dermatitis? Wake Research Associates is enrolling volunteers in a clinical research study testing two, study-related creams to a placebo for individuals with eczema.
Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis
This research study will evaluate the effectiveness and safety of two concentrations (0.5 percent [%] and 1%) and two application frequencies (once a day and twice a day) of GSK2894512 cream for the topical treatment in adolescent and adult subjects with atopic dermatitis (eczema). Results from this study will be ...
Eczema / Atopic Dermatitis
Do you or your child suffer from Atopic Dermatitis or Eczema?
A Phase 2/3 Study Investigating The Pharmacokinetics, Safety, and Efficacy of Dupilumab in Patients Aged Greater Than Or Equal To 6 Months to Less Than 6 Years With Severe Atopic Dermatitis
The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...
969_Atopic Dermatitis Research Study for Children
This study will be testing an investigational medication for the treatment of atopic dermatitis
A Multi-center Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects.
This voluntary study is testing an investigational medicine, called IDP-124, to see if it is safe to use on individuals 12 and older who have Moderate to Severe Atopic Dermatitis. WHAT WILL HAPPEN TO ME IN THIS STUDY? If you are able to be in the study, you, your parent(s) ...
Tralokinumab Monotherapy for Adolescent Subjects with Moderate-to-Severe Atopic Dermatitis
This is a double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of Tralokinumab for the treatment of moderate to severe Atopic Dermatitis. All enrolled participants will receive subcutaneous injections of medication every two weeks for 52 weeks. There are 16 in-office visits throughout the study and ...
Study to Evaluate the Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects
This is a multicenter double-blind, randomized, placebo-controlled study to assess the efficacy and safety of IDP-124 lotion for the treatment of moderate to severe atopic dermatitis (eczema). All enrolled subjects will receive a lotion medication to be applied twice daily for 6 weeks. There are 7 office visits throughout the ...
